Marshall Edwards, Inc.
(NASDAQ:MSHL)|
0.67 -0.10 (-12.99%) Dec 04 - Close |
|
|
|
After-Hours 0.74 +0.07 (10.45%) Thu, 4 Dec 2008 7:40 PM
- Compare MSHL with:
- View: Line | Candlestick
Company Profile
Marshall Edwards, Inc.
140 Wicks Road
NSW, 2113
Australia - Map
Phone: 01161288776196
Fax: 01161298788474
Website: www.marshalledwardsinc.com
State of incorporation: Delaware
CEO: Christopher Naughton
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Dev and commercialize cancer treatment drugs
A developmental stage pharmaceutical company formed for the purpose of development and commercialization of drugs for the treatment of cancer.
Recent news for MSHL
-
Marshall Edwards, Inc. Files IND Application for Triphendiol
Marketwire - Dec 01 at 8:10 ET
-
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
Marketwire - Nov 13 at 8:10 ET
-
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
Marketwire - Nov 12 at 8:10 ET
-
MARSHALL EDWARDS INC Financials
EDGAR Online Financials - Nov 11 at 9:04 ET
-
MARSHALL EDWARDS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 06 at 6:02 ET
-
Marketwire - Oct 30 at 6:18 ET
-
EDGAR Online - Oct 14 at 8:13 ET
-
FY 2008 MARSHALL EDWARDS INC Earnings Release - Time Not Supplied
CCBN - Sep 30 at 6:07 ET
-
MARSHALL EDWARDS INC Financials
EDGAR Online Financials - Sep 18 at 8:04 ET
-
New Star Analyst Rankings for MARSHALL EDWARDS
StarMine - Sep 16 at 8:22 ET